These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

360 related items for PubMed ID: 21422921

  • 21. C3 glomerulopathy: what's in a name?
    D'Agati VD, Bomback AS.
    Kidney Int; 2012 Aug; 82(4):379-81. PubMed ID: 22846813
    [Abstract] [Full Text] [Related]

  • 22. Complement dysregulation in glomerulonephritis.
    Kaartinen K, Safa A, Kotha S, Ratti G, Meri S.
    Semin Immunol; 2019 Oct; 45():101331. PubMed ID: 31711769
    [Abstract] [Full Text] [Related]

  • 23. Pathology after eculizumab in dense deposit disease and C3 GN.
    Herlitz LC, Bomback AS, Markowitz GS, Stokes MB, Smith RN, Colvin RB, Appel GB, D'Agati VD.
    J Am Soc Nephrol; 2012 Jul; 23(7):1229-37. PubMed ID: 22677550
    [Abstract] [Full Text] [Related]

  • 24. Alternative pathway dysfunction in kidney disease: a case report and review of dense deposit disease and C3 glomerulopathy.
    Hawfield A, Iskandar SS, Smith RJ.
    Am J Kidney Dis; 2013 May; 61(5):828-31. PubMed ID: 23391537
    [Abstract] [Full Text] [Related]

  • 25. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.
    Ali A, Schlanger L, Nasr SH, Sethi S, Gorbatkin SM.
    Am J Kidney Dis; 2016 Mar; 67(3):479-82. PubMed ID: 26704376
    [Abstract] [Full Text] [Related]

  • 26. Update on C3 glomerulopathy.
    Barbour TD, Ruseva MM, Pickering MC.
    Nephrol Dial Transplant; 2016 May; 31(5):717-25. PubMed ID: 25326473
    [Abstract] [Full Text] [Related]

  • 27. Dense deposit disease and C3 glomerulopathy.
    Barbour TD, Pickering MC, Terence Cook H.
    Semin Nephrol; 2013 Nov; 33(6):493-507. PubMed ID: 24161036
    [Abstract] [Full Text] [Related]

  • 28. Characterization of C3 in C3 glomerulopathy.
    Sethi S, Vrana JA, Fervenza FC, Theis JD, Sethi A, Kurtin PJ, Zhang Y, Smith RJH.
    Nephrol Dial Transplant; 2017 Mar 01; 32(3):459-465. PubMed ID: 27507892
    [Abstract] [Full Text] [Related]

  • 29. Autoimmune forms of thrombotic microangiopathy and membranoproliferative glomerulonephritis: Indications for a disease spectrum and common pathogenic principles.
    Skerka C, Licht C, Mengel M, Uzonyi B, Strobel S, Zipfel PF, Józsi M.
    Mol Immunol; 2009 Sep 01; 46(14):2801-7. PubMed ID: 19640589
    [Abstract] [Full Text] [Related]

  • 30. Atypical haemolytic uremic syndrome (aHUS) and membranoproliferative glomerulonephritis (MPGN), different diseases or a spectrum of complement-mediated glomerular diseases?
    Ankawi GA, Clark WF.
    BMJ Case Rep; 2017 Aug 10; 2017():. PubMed ID: 28798244
    [Abstract] [Full Text] [Related]

  • 31. Complement and kidney disease.
    Cook HT.
    Curr Opin Nephrol Hypertens; 2013 May 10; 22(3):295-301. PubMed ID: 23508058
    [Abstract] [Full Text] [Related]

  • 32. Treatment of C3 glomerulopathy with complement blockers.
    Vivarelli M, Emma F.
    Semin Thromb Hemost; 2014 Jun 10; 40(4):472-7. PubMed ID: 24799307
    [Abstract] [Full Text] [Related]

  • 33. FHR-5 Serum Levels and CFHR5 Genetic Variations in Patients With Immune Complex-Mediated Membranoproliferative Glomerulonephritis and C3-Glomerulopathy.
    Garam N, Cserhalmi M, Prohászka Z, Szilágyi Á, Veszeli N, Szabó E, Uzonyi B, Iliás A, Aigner C, Schmidt A, Gaggl M, Sunder-Plassmann G, Bajcsi D, Brunner J, Dumfarth A, Cejka D, Flaschberger S, Flögelova H, Haris Á, Hartmann Á, Heilos A, Mueller T, Rusai K, Arbeiter K, Hofer J, Jakab D, Sinkó M, Szigeti E, Bereczki C, Janko V, Kelen K, Reusz GS, Szabó AJ, Klenk N, Kóbor K, Kojc N, Knechtelsdorfer M, Laganovic M, Lungu AC, Meglic A, Rus R, Kersnik Levart T, Macioniene E, Miglinas M, Pawłowska A, Stompór T, Podracka L, Rudnicki M, Mayer G, Rysava R, Reiterova J, Saraga M, Seeman T, Zieg J, Sládková E, Stajic N, Szabó T, Capitanescu A, Stancu S, Tisljar M, Galesic K, Tislér A, Vainumäe I, Windpessl M, Zaoral T, Zlatanova G, Józsi M, Csuka D.
    Front Immunol; 2021 Jun 10; 12():720183. PubMed ID: 34566977
    [Abstract] [Full Text] [Related]

  • 34. Gain-of-function factor H-related 5 protein impairs glomerular complement regulation resulting in kidney damage.
    Malik TH, Gitterman DP, Lavin DP, Lomax-Browne HJ, Hiemeyer EC, Moran LB, Boroviak K, Cook HT, Gilmore AC, Mandwie M, Ahmad A, Alexander IE, Logan GJ, Marchbank KJ, Bradley A, Pickering MC.
    Proc Natl Acad Sci U S A; 2021 Mar 30; 118(13):. PubMed ID: 33753502
    [Abstract] [Full Text] [Related]

  • 35. Morphofunctional Effects of C5 Convertase Blockade in Immune Complex-Mediated Membranoproliferative Glomerulonephritis: Report of Two Cases with Evidence of Terminal Complement Activation.
    Carrara C, Podestà MA, Abbate M, Rizzo P, Piras R, Alberti M, Daina E, Ruggenenti P, Remuzzi G, on behalf of the EAGLE Study Group.
    Nephron; 2020 Mar 30; 144(4):195-203. PubMed ID: 32050203
    [Abstract] [Full Text] [Related]

  • 36. A novel CFHR5 fusion protein causes C3 glomerulopathy in a family without Cypriot ancestry.
    Medjeral-Thomas N, Malik TH, Patel MP, Toth T, Cook HT, Tomson C, Pickering MC.
    Kidney Int; 2014 Apr 30; 85(4):933-7. PubMed ID: 24067434
    [Abstract] [Full Text] [Related]

  • 37. C3 glomerulopathy: A new complement-based entity.
    de Lorenzo A, Tallón S, Hernández-Sevillano B, de Arriba G.
    Rev Clin Esp (Barc); 2014 Apr 30; 214(5):266-74. PubMed ID: 24576419
    [Abstract] [Full Text] [Related]

  • 38. C3 glomerulopathy.
    Servais A, Noël LH, Frémeaux-Bacchi V, Lesavre P.
    Contrib Nephrol; 2013 Apr 30; 181():185-93. PubMed ID: 23689580
    [Abstract] [Full Text] [Related]

  • 39. Evolving complexity of complement-related diseases: C3 glomerulopathy and atypical haemolytic uremic syndrome.
    Cook HT.
    Curr Opin Nephrol Hypertens; 2018 May 30; 27(3):165-170. PubMed ID: 29517501
    [Abstract] [Full Text] [Related]

  • 40. The role of complement in kidney disease.
    Willows J, Brown M, Sheerin NS.
    Clin Med (Lond); 2020 Mar 30; 20(2):156-160. PubMed ID: 32188650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.